We are an ambitious cyanobacterial biologics platform company seeking an outstanding candidate for the role of Research Scientist. As a highly-motivated individual, you will specialise in design, development, delivery and testing of novel cyanobacterial biologics, including monoclonal antibodies, VLP vaccines, & therapeutic proteins. You will tackle a range of challenges as an integral part of the team, and demonstrate a high degree of flexibility, creativity, and initiative. You will have team leadership experience, be adaptable, work well collaboratively, and be able to thrive in a start-up environment.
Key Responsibilities
* Development of genetic designs in collaboration with CTO
* Creation & execution of genetic design strategies, including:
* Design of genetic biologic expression components
* Design of plasmids; Management of build & verification process
* Management of cyanobacteria strain pipeline, including sequence verification
* Working with downstream processing lead to coordinate analysis pipeline
* Support in vitro & preclinical evaluation of biologics, in collaboration with R&D team & CTO
* Updating CTO and Executive on status and timelines for biologics & preclinical material preparation
* Management of lab resources; overseeing smooth functioning of the strain engineering pipeline
* Managing preclinical material production, in collaboration preclinical testing collaborators
Education & ExperienceCritical
* Ph.D. in Bioengineering, Synthetic Biology, Immunology, Microbiology, or closely-related area,
* Competent in microorganism design; hands-on experience with the latest genetic engineering tools, including multi-fragment DNA assembly, cloning, and prokaryotic transformation essential
Advantageous but not essential:
* Industrial/postdoctoral lab experience within biotechnology, immunology, vaccine development or therapeutics
* Experience engineering cyanobacteria
* VLP, mAb and therapeutic protein expression, purification, delivery or testing
* ELISA-based testing & in vitro/in vivo therapeutic characterisation
* Experience with mammalian cell culture & mAb expression
* Conducted preclinical development studies of mAbs, vaccines or therapeutic proteins
* Experience using computational tools for protein design
About the Company
Bondi Bio is an Australian biotechnology company developing a novel platform for the biomanufacture and delivery of biologics using bioengineered cyanobacteria. The platform offers a cost-effective and rapidly-scalable solution to produce monoclonal antibodies, vaccines, and therapeutic proteins. Bondi's food-grade cyanobacteria has the potential for distributed biomanufacturing and point-of-care needle-free delivery. Bondi is working to bring next-generation biologics to market.
#J-18808-Ljbffr